BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0900
-0.0090 (-9.09%)
Apr 7, 2026, 9:59 AM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 33.18 million as of April 7, 2026. Its market cap has decreased by -17.57% in one year.
Market Cap
33.18M
Enterprise Value
33.29M
Revenue
2.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 33.18M, a decrease of -35.84%. That is a compound annual growth rate of -9.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 36.50M | -5.56% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | 51.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 837.78M |
| Australian Clinical Labs | 380.63M |
| Healius | 377.59M |
| Monash IVF Group | 257.16M |
| Rhythm Biosciences | 63.66M |
| Cryosite | 53.45M |
| INOVIQ | 48.57M |
| Microba Life Sciences | 41.41M |